Marlabs has been recognized in the ISG Provider Lens® Life Sciences Digital Services 2026 Global Study, highlighting its capabilities in two key areas: Manufacturing and Supply Chain, and Pharmacovigilance and Regulatory Affairs.
The ISG report evaluates IT service providers and Contract Research Organizations (CROs) on their ability to facilitate digital transformation in the life sciences sector. Marlabs stands out for its expertise in leveraging AI, data, and automation to help life sciences companies streamline operations and enhance their research and development processes.
According to Paige Piani, Chief Revenue Officer at Marlabs, the increasing pressure on life sciences organizations to modernize operations and improve compliance is driving the demand for AI solutions. Marlabs aims to assist clients in transitioning from disjointed digital efforts to cohesive, AI-driven transformations that are grounded in reliable data.
Marlabs promotes a structured approach to AI adoption, encapsulated in its ABCs of AgilityAI framework, which emphasizes alignment, disciplined building, and governance to ensure that organizations can effectively integrate AI into their business models. This strategic focus positions Marlabs as a pivotal partner for organizations aiming to enhance their operational efficiency and accelerate innovation in the life sciences domain.